US 8158601
Lipid formulation
granted A61KA61K31/22A61K31/7088
Quick answer
US patent 8158601 (Lipid formulation) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/22, A61K31/7088, A61K31/712, A61K31/713